Britt Vitalone Net Worth

The estimated Net Worth of Britt J. Vitalone is at least $47 millió dollars as of 24 May 2024. Mr. Vitalone owns over 4,003 units of Mckesson stock worth over $9,334,089 and over the last 6 years he sold MCK stock worth over $32,413,819. In addition, he makes $5,297,280 as Chief Financial Officer és Executive Vice President at Mckesson.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Vitalone MCK stock SEC Form 4 insiders trading

Britt has made over 28 trades of the Mckesson stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 4,003 units of MCK stock worth $2,043,331 on 24 May 2024.

The largest trade he's ever made was selling 27,281 units of Mckesson stock on 27 May 2022 worth over $9,088,938. On average, Britt trades about 6,232 units every 64 days since 2018. As of 24 May 2024 he still owns at least 18,286 units of Mckesson stock.

You can see the complete history of Mr. Vitalone stock trades at the bottom of the page.

Britt Vitalone biography

Britt J. Vitalone CPA serves as Chief Financial Officer, Executive Vice President of the Company. Executive Vice President and Chief Financial Officer since January 2018; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical from July 2014 to December 2017; Senior Vice President and Chief Financial Officer, U.S. Pharmaceutical and Specialty Health from October 2017 to December 2017; Senior Vice President of Corporate Finance and M&A Finance from March 2012 to June 2014. Service with the Company - 14 years.

What is the salary of Britt Vitalone?

As the Chief Financial Officer és Executive Vice President of Mckesson, the total compensation of Britt Vitalone at Mckesson is $5,297,280. There are 2 executives at Mckesson getting paid more, with Brian Tyler having the highest compensation of $15,435,500.

How old is Britt Vitalone?

Britt Vitalone is 51, he's been the Chief Financial Officer és Executive Vice President of Mckesson since 2018. There are 14 older and 2 younger executives at Mckesson. The oldest executive at Mckesson Corporation is Marie Knowles, 73, who is the Independent Director.

What's Britt Vitalone's mailing address?

Britt's mailing address filed with the SEC is 6555 STATE HWY 161, , IRVING, TX, 75039.

Insiders trading at Mckesson

Over the last 21 years, insiders at Mckesson have traded over $302,794,946 worth of Mckesson stock and bought 2,692 units worth $392,568 . The most active insiders traders include John H Hammergren, Andy D Bryant és Paul C Julian. On average, Mckesson executives and independent directors trade stock every 11 days with the average trade being worth of $16,550,831. The most recent stock trade was executed by Brian S. Tyler on 5 September 2024, trading 3,753 units of MCK stock currently worth $2,105,808.

What does Mckesson do?

mckesson corporation, currently ranked 11th on the fortune 500 list, is a healthcare services and information technology company dedicated to making the business of healthcare run better. we partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. mckesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. for more information, visit us at www.mckesson.com.

Complete history of Mr. Vitalone stock trades at Mckesson

Mckesson executives and stock owners

Mckesson executives and other stock owners filed with the SEC include:

• Brian Tyler,
  Chief Executive Officer, Director
• Lori Schechter,
  Executive Vice President, Chief Compliance Officer, General Counsel
• Britt Vitalone,
  Chief Financial Officer, Executive Vice President
• Tracy Faber,
  Chief Human Resource Officer, Executive Vice President
• Edward Mueller,
  Independent Chairman of the Board
• N. Anthony Coles,
  Independent Director
• Dominic Caruso,
  Independent Director
• Marie Knowles,
  Independent Director
• Bradley Lerman,
  Independent Director
• Donald Knauss,
  Independent Director
• Susan Salka,
  Independent Director
• Christine Jacobs,
  Independent Director
• Kenneth Washington,
  Independent Director
• Maria Martinez,
  Independent Director
• Linda Mantia,
  Independent Director
• Tom Rodgers,
  Executive Vice President and Chief Strategy and Business Development Officer
• Nancy Flores,
  Executive Vice President, Chief Technology Officer, Chief Information Officer
• Paul A. Smith,
  Sr. VP of Taxes
• Kirk Kaminsky,
  Pres of The US Pharmaceutical & Specialty Solutions Bus.
• Pete Slone,
  Sr. VP of Corp. Public Affairs
• Holly Weiss,
  Sr. VP of Investor Relations
• Nancy Flores,
  Exec. VP, Chief Information Officer & CTO
• Sundeep G. Reddy,
  Sr. VP, Principal Accounting Officer & Corp. Controller
• Le Ann B Smith,
  EVP & Chief HR Officer
• Michele Lau,
  EVP and Chief Legal Officer
• Webster Roy Dunbar,
  Director
• Kevin M Ozan,
  Director
• Wayne A Budd,
  Director
• Andy D Bryant,
  Director
• James A Beer,
  EVP & Chief Financial Officer
• Kathleen D Mcelligott,
  EVP, CIO & CTO
• John H Hammergren,
  Chairman, President & CEO
• Erin Brewer,
  SVP & Chief Accounting Officer
• Bansi Nagji,
  EVP, Corp Strategy & Bus. Dev.
• Patrick Blake,
  EVP
• Paul C Julian,
  Senior Vice President
• Nigel A Rees,
  Vice President & Controller
• James H. Hinton,
  Director
• Kathleen Wilson Thompson,
  Director
• Sundeep G. Reddy,
  SVP & Controller
• Marc E Owen,
  SVP, Corporate
• Jorge Figueredo,
  EVP, Human Resources
• Cheryl T/Ca Smith,
  SVP & CIO
• Ivan D Meyerson,
  SVP, General Counsel
• Richard F/Ca Syron,
  Director
• James V Napier,
  Director
• Graham O King,
  Senior Vice President
• Pamela J Pure,
  Senior Vice President
• Robert W Matschullat,
  Director
• Paul E Kirincic,
  SVP, Human Resources
• Carl E Reichardt,
  Director
• Tully M Friedman,
  Director
• David M Lawrence,
  Director
• Alton F Iii Irby,
  Director
• Randall N Spratt,
  EVP, CIO
• Jane E Shaw,
  Director
• Laureen Seeger,
  EVP,Gen. Counsel & Secretary
• Jeffrey C Campbell,
  EVP, Chief Financial Officer
• Nancy Avila,
  EVP, CIO & CTO
• Thomas L Rodgers,
  EVP, Chief Strategy & BDO
• Richard H Carmona,
  Director
• Kevin Emerson,
  SVP, Controller & CAO
• Napoleon B Jr Rutledge,
  SVP, Controller & CAO
• Deborah Dunsire,
  Director